The invention provides an oral medication for twice-daily administration, which includes L-cysteine and ascorbic acid resistant preparation for pigmentation treatments of seborrheic keratosis, freckles, suntan, and macula. The twice-daily administration contains L-cysteine or salt thereof and ascorbic acid resistant or salt thereof, in which once dosage of L-cysteine is 90 mg to 150 mg.
